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The two most common forms of COPD, chronic
bronchitis and pulmonary emphysema, will be briefly
reviewed.
Etiology. The causes of COPD are not definitely
known. However, there appears to be a statistically
significant correlation between the incidence of
COPD, cigarette smoking, and air pollution. This is
especially true for chronic bronchitis. In some cases,
genetic factors (alpha 1 - antitrypsin deficiency) may
be responsible for development of COPD. This is
called familial type of COPD or familial emphysema.
Chronic irritation of the tracheobronchial tree is
common to all cases of chronic bronchitis. Cigarette
smoking appears to be the single most important
factor in the development of chronic bronchitis.
Heavy cigarette smokers appear to be affected to a
greater extent than light smokers, and the symptoms
are worse in patients who give a history of long
cigarette smoking. However, not all cigarette smokers
develop chronic bronchitis. Individual susceptibility
may play a role in some people. The symptoms of
smoking are greater if a person lives in a heavily
polluted area and also if there is cold and damp
weather.
The Incidence. It has been estimated that there
are currently 15 million people suffering from COPD
in the United States. The incidence of COPD is
higher in industrial areas, especially among men
who engage in dusty jobs, such as coal miners.
Mortality. In the United States in 1969, 35,000
died primarily from chronic bronchitis and pulmonary emphysema. In 65,000 cases chronic bronchitis
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and pulmonary emphysema contributed to the demise
of the patients. Since 1950, the death rate from
emphysema has doubled every five years. The federal
government pays more than $200,000,000 annually
to respiratory cripples.
Definition. Chronic bronchitis is a clinical syndrome which is characterized by productive cough
on most days during at least three months a year
for two or more successive years. There is chronic
productive cough without known specific causes
such as tuberculosis or chronic suppurative lung
disease. It is more common in males.
There is excessive mucous production with hypertrophy and hyperplasia of the mucous secreting
glands including the Goblet cells. Bronchial mucous
glands are normally located in the bronchi which
contain cartilage in their wall. Hypertrophy of the
gland size can be measured as a gland to wall ratio,
and this is called the Reid Index. In normal people
over the age of four years, this falls below one-third.
In children under the age of four years, the ratio
is a little higher.
A high Reid Index is very suggestive of chronic
bronchitis, but there is no close correlation between
clinical chronic bronchitis and the degree of mucous
gland hypertrophy and hyperplasia. There is also an
overlap of the Reid Index between bronchitis and
non bronchitis.
Clinical and Functional Manifestations of
Chronic Bronchitis. The cardinal manifestation of
chronic bronchitis is productive cough. There is in
general a history of 20-30 years of cigarette smoking.
The disease in general has a slow onset. In the beginning, patients attribute the cough to cigarette smoking. The so-called "cigarette cough" is an early sign of
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bronchitis. In many patients there is also an associated chronic sinusitis. The cough may disappear
if smoking is stopped early enough.
The activity of cilia in the bronchial tree is inhibited by tobacco smoke. As a result of this, movement of mucous bl anket is reduced significantly.
The mucous glands and Goblet cells are stimulated
and they produce more mucous. The result will
be chronic cough and expectoration.
Excessive mucous production increases the tendency to infection which causes further hypersecretion. There develops a vicious cycle of excessive
mucous secretion, infection, and more hypersecretion
results. Tobacco smoke also causes bronchoconstriction which may aggravate the symptoms of bronchitis.
Norm ally the lower respiratory tract is essentially sterile. This is primarily due to cough reflexes, mucociliary, and alveolar macrophagic
activity that eliminates bacteria or foreign particles
that may have been inhaled during inspiration.
In chronic bronchitis many organisms can be
isolated from the sputum which may be responsible
for acute exacerbations. However, viruses probably are responsible to a great extent for the acute
episodes in chronic bronchitis.
Following viral infections, as a result of damage
to bronchial mucous, growth of bacteria may be encouraged. Diplococcus pneumoniae and Hemophilus
influenzae appear to be important organisms; however, sometimes Staphylococcus aureus and the
Friedlander's bacillus may be responsible for acute
infection . Some patients trace the beginning of
symptoms to some acute episode of infection such
as bronchopneumonia.
In general there is fluctuation in the manifestations during the course of the disease. Symptoms become worse after exposure to cold, damp, or
foggy weather or to irritants. However, during the
end-stage of the disease the patients are, more or
less, continuously symptomatic. Death secondary to
pneumonia, congestive heart failure, or acute respiratory failure may occur 15 to 30 years after the
beginning of symptoms. In a typical bronchitic,
sputum is usually mucoid which becomes mucopurulent during acute bronchopulmonary infections.
Dyspnea may also occur during episodes of
acute bronchoconstriction secondary to infections,
irritants, and so forth. It may also indicate development complicating pulmonary emphysema. Intermittent wheezing may also be present.
Dyspnea, cough, and wheezing may awaken

the patient, and the picture may be confused
with paroxysmal nocturnal dyspnea due to left-sided
heart failure. But in bronchitis the symptoms are
generally improved by expectoration of sputum. The
body weight of thes'e patients is generally normal or
heavy.
Arterial gas abnormalities are quite common.
Many patients have hypoxemia alone. CO~ retention
takes place late in the course of the disease or
during acute episodes of bronchopulmonary infection.
When hypoxemia and respiratory acidosis are
present, pulmonary hypertension develops which
may result in cor pulmonale.
There is a high incidence of erythrocytosis
resulting from hypoxemia. Many patients later in
the course of the disease have florid appearance
and cyanosis. Because of increased incidence of
congestive heart failure and cyanosis, the patients
are called "Blue Bloaters."
The amount of airway obstruction will influence the physical signs. In advanced stages, the
thoracic cage is in the inspiratory position. There
is kyphosis of the dorsal spine. The anteroposterior
diameter of the chest increases. There is excessive
use of accessory respiratory muscles. The degree
of scalene muscle contraction may give an idea
about the extent of airway obstruction. In general,
the breath sounds are normal. Ronchi are present
in most patients.
In the early stages of chronic bronchitis and
pulmonary emphysema, there is a significant degree of involvement of the small airways. It should
be emphasized that small airways (2 mm or less in
diameter) are only responsible for approximately
15 to 20 % of the total airway resistance ; thus,
marked increases in peripheral or small airways will
not be detected by the conventional tests such as
FEV 1 (forced expiratory volume in one second)
or MMFR (maximum mid expiratory flow rate).
In the early stages of these conditions, frequencydependent dynamic compliance studies and alveolararterial 0 2 tension gradient, A-a P 0 ,, may detect
pulmonary dysfunction. For clinical purposes, however, simple spirometric studies with measurements
of FVC (forced vital capacity), FEV 1 and MMFR
are satisfactory.
Improvements in flow rates after administration
of bronchodilating agents indicate the presence of
partially reversible obstruction.
In established chronic bronchitis, there is
over-expansion of the lungs with enlargement of
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residual volume and FRC (functional residual capacity). VC ( vital capacity) is either normal or
decreased. The total lung capacity may be normal
or increased. The ratio between FEV 1 and FVC,
and the maximal mid expiratory flow rate are reduced.
Radiologic Findings. In simple or uncomplicated
chronic bronchitis, the chest x-ray may be normal.
There may be over-expansion of the lungs and the
diaphragm may be depressed.
Some cases would show "tram lines" or parallel
shadows and prominence of the lung markings mainly
at the bases. Prominence of the main pulmonary
artery may suggest pulmonary hypertension. Bronchograms may demonstrate tiny diverticulum-like
shadows in the large bronchi. Irregularity of the
caliber of segmental and subsegmental bronchi is
frequently seen.
Pulmonary Emphysema. Pulmonary emphysema
is accurately defined in morphologic terms only. It
is defined by increase beyond normal in the size
of air spaces distal to the terminal bronchioles,
with destruction of the walls of these air spaces. It
is a destructive process. There is reduction in elastic
retractive force of the lungs.
The portion of the lung distal to the terminal
bronchiole is called acinus, and it contains respiratory
bronchioles, alveolar ducts, alveolar sacs, and alveoli.
It is in this area that gas exchange takes place. For
this reason, acinus is considered as the basic functioning unit of the lungs which is analogous to the
nephron of the kidney.
In panacinar emphysema, there is involvement
of the entire acinus. In centriacinar emphysema,
only those alveoli near the center of the acinus are
affected. The centriacinar type is more common in
the upper two-thirds, and the panacinar is roughly
uniform, commonly affecting the basal regions of
the lungs.
Many patients have both types of emphysema
together; however, centriacinar is much more common than panacinar and is in general associated
with chronic bronchitis and chronic respiratory irritation. Dr. W. M. Thurlbeck found panacinar as
often in women as men, while the centriacinar was
more common in men.
Emphysema is more common in patients with
bronchitis than in nonbronchitics. There is also a
higher incidence of emphysema in patients with
extensive bronchiectasis. This is also true in other
chronic inflammatory diseases of the lungs, especially when both lungs are diffusely affected. On the
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other hand, emphysema is rarely found in the postmortem studies of the lungs of patients with bronchial
asthma.
Clinical and Functional Manifestations. The
main symptom of emphysema is dyspnea which
has an insidious onset and becomes manifested on
exertion. Dyspnea gradually increases, and in advanced stages, ordinary daily activities may induce
severe shortness of breath.
Cough may be absent or insignificant during
the early course of the disease. Episodes of severe
dyspnea and wheezing may occur, usually during
acute bronchopulmonary infections or after exposure
to irritants. In general, the body weight is below
normal, and loss of weight is common in emphysematous patients.
The anteroposterior diameter of the chest is
increased. Breath sounds are distant. The heart
sounds are frequently inaudible. They may be heard
easily in the epigastric area. There is a higher incidence of peptic ulcer disease in patients with
emphysema. The exact cause of this is unknown at
the present time.
Airway resistance is increased especially during expiration. Static compliance of the lungs is
greater than normal. However, frequency dependent
compliance studies are generally abnormal. Residual
volume, FRC, and TLC (total lung capacity) are
frequently elevated. VC may be normal or reduced
due to increased RV and FRC. There is obstruction
to airflow. FEV 1 , MMFR, and MVV (maximal
voluntary ventilation) are diminished.
X-ray Findings. In mild pulmonary emphysema
the chest x-ray may be normal. In some cases there
is x-ray evidence of over-expansion of the lungs
which is a nonspecific finding that is seen in cases
of diffuse bronchial obstruction such as bronchial
asthma and chronic bronchitis. If, in addition to overexpansion, there is marked reduction or absence of
peripheral vascular markings associated with engorged hilar pulmonary vessels and blebs bullae,
presence of underlying emphysema is almost certain.
The heart shadow is usually long and narrow.
Arterial gas studies reveal only mild abnormalities
at least during early stages of the disease. Patients
attempt to maintain a relatively normal P 0 , and Pc 0 ,.
Because of this, these patients are called " Pink
Puffers." The incidence of cor pulmonale is less
frequent in Pink Puffers as compared with Blue
Bloaters.
There are two primary factors responsible for
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TABLE 1.
MAIN MANIFFSTATIONS OF PURE CHRONIC BRONCHITIS
OR PULMONARY EMPHYSEMA
(Blue Bloater)
Chronic
Bronchitis
Cough
Dyspnea
Body Weight
Arterial Gas
Abnormalities
Cor Pulmonale
Erythrocytosis
Breath Sounds

(Pink Puffer)
Pulmonary
Emphysema

++++

±

±

++++
thin

normal or
heavy
++++
++++
++++
normal

+
+ (Terminally)
+
diminished

± : Insignificant
+: Increase
+ + + +: Significant increase

the development of pulmonary hypertension in patients with COPD: 1) Functional or reversible factors due to hypoxemia and hypercapnia, 2) Irreversible factors due to loss or occlusion of pulmonary
capillaries.
Functional factors are mainly responsible, and
they play a major role in the production of pulmonary
hypertension. Since there are in general more dis~
turbed arterial gas tensions in bronchitis, incidence of
pulmonary hypertension and cor pulmonale are
higher in bronchitics.
In over 90% of the cases of COPD, patients
have combined chronic bronchitis and pulmonary
emphysema. Some of these patients have predominantly chronic bronchitis and some predominantly
pulmonary emphysema. However, a very small percentage of . these patients would only have either
chronic bronchitis or pure pulmonary emphysema.

TABLE 2.
CAUSES OF ACUTE RESPIRATORY FAILURE IN COPD
1.
2.
3.
4.
5.
6.
7.
8.
9.

Bronchopulmonary infections.
Heavy sedation and anesthesia.
Improper use of oxygen.
Pulmonary edema and congestion.
Thoracotomy, abdominal surgery.
Atelectasis or pneumothorax.
Dehydration.
Pulmonary embolism.
Severe episode of air pollution.

TABLE 3.
THE FINDINGS THAT MAY INDICATE POOR PROGNOSIS
IN COPD

1.
2.
3.
4.
5.
6.

Recent significant weight loss.
Persistent tachycardia at rest.
Presence of cor pulmonale.
FEV1 less than 750 ml.
Persistent severe hypoxemia and hypercapnia.
Marked reduction in pulmonary diffusion capacity.

If manifestations due to pure chronic bronchitis
or emphysema are appreciated, one may have some
opinion as to symptoms and signs primarily related
to either chronic bronchitis or pulmonary emphysema (Table 1 ) . It has been shown that chronic
bronchitis does not necessarily always lead to pulmonary emphysema nor does pulmonary emphysema always lead to chronic bronchitis.
Table 2 shows causes of acute respiratory failure
in patients who have chronic respiratory failure
with COPD. Finally, Table 3 shows factors that
may indicate poor prognosis in patients with COPD.
Comment. There are currently 15 million people affected with COPD in the United States. It
appears that once the disease is well established or
advanced, the ultimate course cannot be altered
significantly. Emphasis should be given upon prophylactic measures. Discouragement of cigarette
smoking is probably the most important means to
reduce the incidence of COPD.
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